Kessel-lo, Belgium

Georges Joseph Cornelius Hoornaert

This inventor holds 6 USPTO granted patents. Top assignees: Janssen Pharmaceutica Nv, Other. Active years: 2006-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Georges Joseph Cornelius Hoornaert. Retrieved from https://idiyas.com/inventor/georges-joseph-cornelius-hoornaert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 16.7

Average Co-Inventor Count = 7.7

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • Leuven, BE (2007)
  • Kessel-Lo, BE (2006 - 2013)

Company Filing History:


Years Active: 2006-2013

Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Georges Joseph Cornelius Hoornaert: A Pioneer in Pharmaceutical Innovations**

Introduction

Georges Joseph Cornelius Hoornaert, hailing from Kessel-Lo, Belgium, is a distinguished inventor with a remarkable portfolio comprising six patents. His work primarily revolves around the development of innovative pharmaceutical compounds aimed at addressing various psychiatric, neurological, and infectious diseases. Hoornaert's ingenuity in the field of medicinal chemistry has earned him recognition as a key figure in pharmaceutical innovation.

Latest Patents

Among his latest patents is the invention of substituted tetracyclic tetrahydrofuran, pyrrolidine, and tetrahydrothiophene derivatives. This groundbreaking work focuses on novel compounds with significant binding affinities towards serotonin receptors, particularly the 5-HT and D2 dopamine receptors. These compounds exhibit properties that inhibit norepinephrine reuptake, making them potential candidates for treating a variety of psychiatric and neurological disorders, as well as certain psychotic, cardiovascular, and gastrokinetic disorders. Not only do these derivatives represent a step forward in medicinal chemistry, but they can also be utilized in various pharmaceutical compositions for medical use.

Another notable patent involves HIV replication inhibitors in the form of 1,2,4-triazin-6-one derivatives. This invention outlines compounds with the potential to combat HIV infection, showcasing their capability as medicines for the treatment or prevention of this serious viral condition. The compounds possess structurally diverse components that enhance their pharmacological efficacy, positioning them as valuable assets in the fight against HIV.

Career Highlights

Hoornaert has made significant contributions while working in esteemed organizations, including Janssen Pharmaceutica, where he applied his expertise in the development of innovative pharmaceutical solutions. Through his dedication and innovative spirit, he has propelled advancements in medicinal chemistry and pharmaceutical development, contributing significantly to the industry and improving patient outcomes.

Collaborations

Hoornaert’s works have been enriched by collaborations with talented individuals in his field. Notable coworkers, such as Frans Josef Cornelius Compernolle and Tomasz Kozlecki, have collaborated closely with him, creating an environment for innovation and shared expertise that has undoubtedly influenced his productive career.

Conclusion

Georges Joseph Cornelius Hoornaert exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through numerous patents reflect a commitment to advancing medical treatments and improving health outcomes. As he continues to explore the frontiers of medicinal chemistry, Hoornaert remains an influential figure worthy of recognition in the landscape of pharmaceutical inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…